Comparative Study Assessing Multiple Switches Between Biosimilar ABP 501 (adalimumab-atto) and Adalimumab Reference Product in Patients with Plaque Psoriasis.
Saved in:
| Title: | Comparative Study Assessing Multiple Switches Between Biosimilar ABP 501 (adalimumab-atto) and Adalimumab Reference Product in Patients with Plaque Psoriasis. |
|---|---|
| Authors: | Yamauchi PS; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Chow V; Amgen Inc, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA., Mytych DT; Amgen Inc, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA., Zhou M; Amgen Inc, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA., Radziszewski W; Amgen Inc, One Amgen Center Dr., Thousand Oaks, CA, 91320, USA. wradzisz@amgen.com. |
| Source: | Advances in therapy [Adv Ther] 2026 Jun; Vol. 43 (6), pp. 2795-2808. Date of Electronic Publication: 2026 Apr 09. |
| Publication Type: | Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1865-8652 |
|---|---|
| DOI: | 10.1007/s12325-026-03574-8 |
